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neutralize the 2009 pandemic H1N1 influenza HA through a similar epitope. However, the detailed mechanism of neutralization
remains unclear. We conducted molecular dynamics (MD) simulations to study the interactions between Ig-2D1 and the HAs
from the 1918 pandemic flu (A/South Carolina/1/1918, 18HA), the 2009 pandemic flu (A/California/04/2009, 09HA), a 2009
pandemic flu mutant (A/California/04/2009, 09HA_mut), and the 2006 seasonal flu (A/Solomon Islands/3/2006, 06HA).
MM-PBSA analyses suggest the approximate free energy of binding (DG) between Ig-2D1 and 18HA is74.4 kcal/mol. In com-
parison with 18HA, 09HA and 06HA bind Ig-2D1 ~6 kcal/mol (DDG) weaker, and the 09HA_mut bind Ig-2D1 only half as strong.
We also analyzed the contributions of individual epitope residues using the free-energy decomposition method. Two important
salt bridges are found between the HAs and Ig-2D1. In 09HA, a serine-to-asparagine mutation coincided with a salt bridge desta-
bilization, hydrogen bond losses, and a water pocket formation between 09HA and Ig-2D1. In 09HA_mut, a lysine-to-glutamic-
acid mutation leads to the loss of both salt bridges and destabilizes interactions with Ig-2D1. Even though 06HA has a similarDG
to 09HA, it is not recognized by Ig-2D1 in vivo. Because 06HA contains two potential glycosylation sites that could mask the
epitope, our results suggest that Ig-2D1 may be active against 06HA only in the absence of glycosylation. Overall, our simulation
results are in good agreement with observations from biological experiments and offer novel mechanistic insights, to our knowl-
edge, into the immune escape of the influenza virus.INTRODUCTIONInfluenza virus gains entry into the human body through in-
teractions of the viral surface glycoproteins called hemag-
glutinin (HA) with the sialic acid (Sia) receptors on the
human epithelial cell surface (1,2). Sia is found at the termi-
nals of glycans attached covalently to cell surface glycopro-
teins or glycolipids. They are also found on the viral surface
proteins (3). During viral infection, viral HA binds to Sia re-
ceptors on human host cells, and the virus enters through
endocytosis. The flu virus then usurps host cell machineries
for viral replication (4). There are 18 known HA serotypes:
H1 to H18. Among these serotypes, H1 and H5 are the most
extensively studied. H1 is found to bind preferentially to Sia
with an a-2,6 glycosidic bond, whereas H5 prefers Sia with
a-2,3 linkage (5).
Humans fight influenza infection through innate and
adaptive immune responses (6) including vaccination or
use of pharmaceutical drugs such as Tamiflu or Relenza
(7). The adaptive immune response involves the recognition
of HA epitopes by human immune cells and the production
of antibodies against HA. Inactivated, live attenuated virus
or recombinant HA are often prepared as vaccines, whichSubmitted September 30, 2014, and accepted for publication April 9, 2015.
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0006-3495/15/06/2704/9 $2.00elicit antibody production 7 days after inoculation (8). An-
tibodies bind HA epitopes, preventing Sia binding and endo-
cytosis (9). Four main canonical epitopes on the globular
HA head have been identified: Sa, Ca, Sb, and Cb (Fig. 1)
(10,11). More recently, cross-reacting antibodies against
multiple HA subtypes have been discovered that target the
globular epitopes and the conserved stem regions (12–14).
Preexisting antibodies from vaccination or earlier infections
may prevent infection by viral strains with similar HA epi-
topes (8,15).
Influenza viruses avoid human immune responses
through antigenic drift and antigenic shift. In antigenic drift,
mutations in glycoprotein epitopes render existing anti-
bodies ineffective, a process facilitated by the high mutation
rate of the influenza RNA genome (16). As a result, annual
vaccines may offer partial protection or fail completely
against unanticipated strains. In antigenic shift, abrupt
changes in viral RNA genome result when several different
viral strains recombine, creating a hybrid virus. The result-
ing virus is novel and distinctive, to our knowledge, some-
times posing lethal threats to the human population. The
2009 swine flu, which emerged from a triple assortment
involving swine, human, and avian reservoirs, is a good
example (17). Since it first appeared in the human popula-
tion in April 2009, it quickly spread globally and was
declared pandemic by the World Health Organization in
June 2009 (18).http://dx.doi.org/10.1016/j.bpj.2015.04.025
FIGURE 1 Sequence alignment and the epitopes
of the four HA glycoprotein. (A) Sequence align-
ment and structural view. The four HA sequences
are aligned and numbered using the 18HA
numbering convention. On the right, the Sa epitope
is colored red and the surrounding residues that
form contact with Ig-2D1 (12) are colored blue
(top left) in 18HA monomer 1. (B) Structural con-
servation of the HA epitope region and key muta-
tions that affect antibody recognition. The four
HAs are shown: (a) 18HA, (b) 06HA, (c) 09HA,
and (d) 09HA_mut. The epitope residues on mono-
mer 1 are colored by residue names. Several key
residues are also labeled to their corresponding res-
idue colors. S160 (18HA) is mutated in N160 in
09HA. K 167 (09HA) is mutated to E167 in
09HA_mut. N129 and N164 in 06HA are potential
glycosylation sites. To see this figure in color, go
online.
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sonal flu, few from this age group have been infected by
the 2009 pandemic strain (19). Some researchers have hy-
pothesized that the elderly may be immune because of child-
hood exposure to the 1918 pandemic flu virus (18HA). The
09HA is found to be very similar, genetically and structur-
ally, to the 18HA. Therefore, it is possible that antibodies
that recognize the 18HA may also recognize the 09HA
(12,20). Krause et al. showed that monoclonal immunoglob-
ulin (Ig-2D1) against the 18HA appeared to cross-react with
the 09HA from the pandemic flu (14).
To identify specific mutations that might affect HA bind-
ing, Liu et al. used computational methods to predict hot-
spot residues on the epitopes of the 09HA, 18HA, and
07HA from a 2007 seasonal strain (07HA) that interacts
with Ig-2D1 (21). They suggested that mutations in the
18HA and 09HA at residues P128, N129, K158, P163,
K164, and K167 (using 18HA numbering) could disable
Ig-2D1 neutralization. Because N160 was not predicted as
a hot-spot residue, Liu et al. proposed that a mutation
from S160 in the 18HA to N160 in the 09HA would not
affect binding. Their analysis of the binding between Ig-
2D1 and the various HAs was performed on crystal struc-
tures, and protein flexibility was not considered explicitly.
In this article, we present new findings, to our knowledge,
using molecular dynamics (MD) simulation in four
influenza H1N1 systems of Ig-2D1 and HAs: A/South
Carolina/1/1918, A/California/04/2009, A/Solomon Island/3/2006, and A/California/04/2009 mutant. We explore the
underlying molecular interactions that govern Ig-2D1/HA
binding to determine how Ig-2D1 is able to elicit a cross-
reactive immune response to the 2009 influenza virus. Our
results are in good agreement with previous experimental
and computational studies. Additionally, we discovered
that mutations such as the S160N mutation in 09HA do
affect the stability of the antibody-antigen interaction.MATERIALS AND METHODS
Simulation setup
The structures of the 06HA, 09HA, and 18HAwere obtained from the Pro-
tein Data Bank (PDB) (12,22) with PDB ID 3SM5, 3LZG, and 3LZF,
respectively. Only the 18HAwas co-crystallized with Ig-2D1 (12). Seasonal
strain HA and 09HA were superimposed on the 18HA structure to model
Ig-2D1 binding to these HA variants. The numbering scheme for Ig-2D1
was adapted from the PDB structure. The trimetric units of HA were
built after the superimposition according to the biological unit (23). The
09HA_mut and 09HA model differ by one single residue at position 167.
It was prepared from the 09HA system by mutating the residue from K
to E (K167E) using Schro¨dinger (24).Molecular dynamics simulation
Four systems (18HA, 09HA, 06HA, and 09HA_mut) were parameterized
with the Amber ff99SB force field (25). The systems were first neutralized
by adding sodium ions. Additional ions were then added to achieve 20 mM
NaCl buffer salt concentration. Histidine charges were assigned usingBiophysical Journal 108(11) 2704–2712
2706 Ieong et al.PROPKA from the pdb2pqr web server at pH 7.0 (26,27). Each system was
solvated in a water box of ~150  160  210 A˚ using the TIP3P (28) water
model. Each system had a total of ~500,000 atoms (Table S1 in the Support-
ing Material). MD simulations were performed afterward using NAMD
2.9 (29).
The systems were constrained and gradually minimized to reduce the to-
tal potential energy in a series of four steps of energy minimization. The
first step kept all heavy atoms constrained, and only hydrogen atoms
were allowed to fluctuate. The second step released the constraints on water
and ions. The third steps freed the side chains. In the fourth step, all atoms
were allowed to move without restriction. The nonbonded energy was
calculated every two time steps with a cutoff distance of 12 A˚. A switching
function was applied at 10 A˚ to abridge the van der Waals potential
function.
After minimization, four steps of equilibration were performed, gradu-
ally loosening harmonic constraints in 500 ps increments, for a total equil-
ibration time of 2 ns. The first step heated the system to 310 K while
applying a force of 4 kcal/mol to hold the backbone in place. The remaining
three steps gradually lifted the backbone constraint force from 4 kcal/mol to
1 kcal/mol. NPT ensemble was completed. Langevin Dynamic was applied
to keep the temperature constant throughout the equilibration, with a damp-
ing frequency of 5 ps/THz, and Langevin Priston barostat helped maintain
the specified one atmospheric pressure. The constraints applied during
equilibration were removed for the free simulation of the antigen-antibody
complexes. All simulations were run for 69 ns using the XSEDE resources
Ranger, Stampede, (both at TACC) and Gordon (SDSC).Determining bond interactions
Barlow and Thornton proposed that salt bridges should be between oppo-
sitely charged residues %4.0 A˚ (30). Xu et al. reported that three salt
bridges were found between the antigen-antibody interfaces in their
Ig-2D1 and 18HA co-crystal structure (12). K158 interacts with the Ig
heavy chain (IgH) D52 and D54, forming two distinct salt bridges, with
bond distances of 3.7 A˚ and 3.0 A˚, respectively. Additionally, K167 inter-
acts with D93 on the Ig light chain (IgL) with a bond distance of 2.8 A˚. For
the purpose of this investigation, we defined a salt bridge to be between a
pair of oppositely charged groups that contain at least one hydrogen bond
within 3.5 A˚ of each other, as suggested by other researchers (31). This
is because the H-bond may be important in the stability of salt bridges
(31), as also supported later in this article.
We used the Visual Molecular Dynamics (VMD) software package (32)
to analyze simulation trajectories. Xu et al. proposed a list of 18HA residues
that interacted with Ig-2D1 (12). All reported interactions between Ig-2D1
and the different HAs were determined carefully based on atomic character-
istics and a distance matrix. They included hydrogen bonds, salt bridges,
and dipole-dipole and van der Waals interactions (e.g., Fig. S1). The dis-
tances between contacting atoms were recorded every 100 ps. The distance
cutoffs were%3.5 A˚ for hydrogen bonds,%3.5 A˚ for salt bridges, and 2.6–
4.6 A˚ for dipole-dipole interactions and van Del Waal interactions. To ac-
count for system dynamics and to capture the stability of the interactions,
we calculated an interaction percentage using the distance matrix for
each contact made between epitope residues and Ig-2D1. Only interactions
present in at least two of the three monomers for 75% or more of the simu-
lation time were considered important for the binding of HAs and Ig-2D1.
Similarly, surrounding residues near the reported Sa epitope were also
analyzed to identify possible contacts with Ig-2D1 found through simula-
tion that had not been reported previously.Free energy of binding and decomposition
The free energy of binding (DG) was approximated using the Molecular
Mechanics–Poisson-Boltzmann Surface Area (MM-PBSA) method
using MMPBSA.py implemented in AmberTools11 (33,34). TheBiophysical Journal 108(11) 2704–2712Poisson-Boltzmann (PB) equation was utilized to estimate the polar contri-
bution of the solvation energy. MMPBSA.py stripped the water molecules
and ions and carried out the calculation in implicit solvent. The ionic
strength for the free-energy calculation was also set to 20 mM. The receptor
mask was set to the trimetric HA plus two Ig-2D1, and the ligand mask was
always set to the remaining Ig-2D1. Thus, three free-energy calculations
were performed to obtain the mean and standard error (SE) of DG for
each system.
Per-residue free-energy decomposition was carried out to determine the
energy contribution of epitope residues to the binding with Ig-2D1, using
the MMPBSA.py tool from AmberTools13 (33,34). The Generalized
Born (GB) implicit-solvent model was utilized for the decomposition calcu-
lation. Since GB was parameterized with the atomic radii mbondi2 (35), all
the atom radii were changed from the default mbondi to mbondi2. Saltcon
was also set to 20 mM. All other parameters were identical to those in
AmberTools11. The decomposition analysis of individual residues was per-
formed using igb2, not the default GB parameter (igb5). In a comparison of
igb5 and igb2, we found that the DG calculated from igb2 was closer to the
PB energy (data not shown). This result, consistent with that from our pre-
vious study, indicates that igb2 is well suited to the neuraminidase N1 and
N9 systems (36).RMSD and surface pocket volume calculations
UCSF Chimera was utilized to calculate the RMSD between crystal struc-
tures. Clustal Omega was applied to alignment the HA sequences (23,37).
The POVME 2.0 software (38) was used to calculate the surface pocket vol-
umes at the interface of HAs and Ig-2D1 near residue S/N160 in 18HA and
09HA. A 12 A˚ radius sphere was centered on the S/N160 center of mass
fully covering S/N160 and surrounding Ig-2D1 residues. The volume calcu-
lations were done separately for each monomer, and an average was re-
ported for each system. A cylinder (25 A˚ in radius and 4 A˚ tall) that
fully encompassed the interface was used to calculate the volume between
the antibody-antigen interface in the 09HA and 09HA_mut systems. The
center of the cylinder was positioned at the center of mass of all epitope res-
idues, and oriented toward (1, 0, 4) for Ig1, (4, 1, 0) for Ig2, and (1, 4, 0)
for Ig3.RESULTS
Structure and sequence alignments
The 18HA, 09HA, and 06HA selected in this study are
structurally conserved (12), with RMSD values of 0.851 A˚
(09HA) and 0.927 A˚ (06HA), in comparison with the
18HA (Fig. 1). Of the 20 HA epitope residues known to
interact with Ig-2D1 in the 18HA, two mutations were found
in the 09HA and 10 mutations in the 06HA. As reported
earlier, 06HA contained two glycosylation sites N129 and
N164 (NxS/T, where x is any amino acid other than proline),
because of an E131T mutation and a K164N mutation
(Fig. 1) (22).Bond interactions
In Table 1, we compare the number of bond interactions be-
tween HA epitope residues and Ig-2D1. The heavy and light
chains of Ig-2D1 are indicated using IgH and IgL, respec-
tively. Notably, from the single-point mutation from the
09HA to the 09HA_mut, three H-bonds between S126,
K167, and S168 (09HA) and D93, N31, and S30 (IgL)
TABLE 1 Interactions between HA and Ig-2D1 systems
categorized by bond types
Salt Bridge H-Bond Dipole-Dipole van der Waals
18HA 2 11 23 4
06HA 1 6 11 4
09HA 1 6 11 5
09HA_mut 0 4 11 5
H-bond stands for hydrogen bond. Dipole-dipole stands for dipole-dipole
interactions. A salt bridge is formed between negatively and positively
charged residues within 3.5A˚ of each other. The van der Waals force is
the interaction between hydrophobic residues. More details are in Tables
S2–S5. Table S2 also indicates interactions found in crystal structure
only for 18HA.
Immune Recognition and Escape for H1N1 2707were lost, respectively, whereas a new H-bond interaction
was formed between Y162 (09HA_mut) and S99 (IgH).
This is a net loss of two H-bonds between the 09HA and
09HA_mut.
In the 18HA, K158 and K167 form two distinct salt
bridges with D54 (IgH) and D93 (IgL) in the Ig-2D1. These
two lysine residues are conserved in all naturally occurring
HAs (Fig. 1).
By contrast, the 09HA system has only one salt bridge
(K167-D93). An earlier study by Krause et al. suggested
that mutations of K167 in the 09HA to E or N (K167E/N)
allow the 09HA to escape neutralization from monoclonal
antibody Ig-2D1 (14). We recreated the 09HA_mut carrying
the K167E mutation in silico, and the resulting mutant lost
both salt bridges. Overall, the Ig-2D1 lost about half of the
H-bond and dipole-dipole interactions in the 09HA and
09HA_mut systems compared with the original 18HA sys-
tem. Together, these observations suggest that the Ig-2D1
may not bind as strongly to the more recent HAs because
of loss of these interactions.Free energy of binding calculation
The approximate average DG for each system was obtained
using the MM-PBSA method (33). The 18HA had the
lowest DG with respect to Ig-2D1 (Table 2) at 74.4 5
1.1 kcal/mol. The 09HA and the 06HA systems were
~6 kcal/mol lower (DDG), with similar DG values of
68.0 5 1.2 kcal/mol and 67.6 5 1.6 kcal/mol, respec-
tively (Table 2). The calculated DG values are consistent
with the observed number of interaction shown in Table 1.
Both the 09HA and 06HA had higher DDGs comparedTABLE 2 Estimated DG free energy of binding for each system us
18HA (N ¼ 248) 06HA (N ¼ 248
Average SE Average
PB DGsubtotal 74.4 1.1 67.6
GB DGsubtotal 74.5 1.0 63.4
N is the number of frames used in the calculation. Each frame is ~0.28 ns of the s
three sample runs in each system. All values are in kcal/mol. Only DGsubtotal iswith the 18HA by þ6.4 5 1.6 kcal/mol and þ6.8 5
1.9 kcal/mol, respectively. In contrast, the average DG of
the 09HA_mut was significantly higher: þ36.5 5
1.9 kcal/mol than that of 18HA. Compared with that of
09HA, the DG of the 09HA_mut system increased
by þ30.1 5 2.0 kcal/mol, even though the only difference
was a K167E mutation in 09HA_mut. The 09HA_mut DG
result is in agreement with the K167E escape mutant
selected by Krause et al. (14). The MM-GBSA method
also gave very similar results (Table 2).Free-energy decomposition
To further study the contribution of each epitope residue and
probe the importance of K167, we performed free-energy
decomposition using MM-GBSA (Tables 3 and S8). The
average DG of the binding-energy contribution from K167
was predicted to be6.65 0.2 kcal/mol in 18HA, the high-
est contribution of all the epitope residues. This is also true
in the 09HA and 06HA systems: the DG of the binding-en-
ergy contributions of K167 are 6.3 5 0.2 kcal/mol and
6.6 5 0.2 kcal/mol, respectively. Krause et al. identified
an escape mutation K167E that prevents Ig-2D1 from
neutralizing 09HA (14). In the K167E 09HA_mut system,
the free-energy decomposition results showed that this
mutation was highly unfavorable, with a DG contribution
of þ2.9 5 0.1 kcal/mol (Table 3). The mutation increased
the residue decomposition energy by þ9.2 5 0.3 kcal/mol.
Putting a negatively charged glutamic acid residue in the
place of a positively charged lysine residue would lead to
electrostatic repulsion with structural consequences on the
HA-Ig2D1 complex.
Mechanistic insight from the 09HA immune escape mutation
During the minimization step of the 09HA_mut system, the
complementarity-determining region (CDR) L3 loop con-
taining D93 (IgL), the salt bridge partner with K167
(09HA), shifted away from E167 (09HA_mut) (Fig. 2).
E167 (09HA_mut) then formed two hydrogen bonds inter-
acting with S30 and N31 (IgL) in the CDR L1 loop. Initially,
the CDR L1 loop maintained these hydrogen bonds (Fig. 2
A). Both the L1 and L3 loops had shifted away from E167
and the antigen at the end of the simulation (Fig. 2 B).
The number of atoms within 4.6 A˚ of E167 from the CDR
L1 and L3 loops dropped from 13 atoms to around 4 atoms
as early as 3 ns into the simulation (Fig. 2 C). The movementing MM-PB/GBSA
) 09HA (N ¼ 249) 09HA_Mut (N ¼ 247)
SE Average SE Average SE
1.6 68.0 1.2 37.9 1.6
1.5 62.7 1.1 39.1 1.1
imulations. Average DG energy and standard error (SE) are calculated from
reported. The individual components are reported in Tables S6 and S7.
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TABLE 3 Free-energy decomposition of epitope residues in the four systems
18HA 06HA 09HA 09HA_mut
Residue ID Residue DG5 SE Residue DG5 SE Residue DG5 SE Residue DG5 SE
158 K 4.45 0.2 – 2.2 5 0.2 – 2.35 0.2 – 1.95 0.2
159 G 3.15 0.1 N 2.9 5 0.1 – 2.25 0.1 – 1.85 0.1
160 S 4.95 0.2 G 0.0 5 0.0 N 0.55 0.1 N 0.95 0.1
161 S 1.85 0.1 L 4.0 5 0.1 – 1.85 0.1 – 2.05 0.1
167 K 6.65 0.2 – 6.6 5 0.2 – 6.35 0.2 E 2.95 0.1
Only selected key residues—158, 159, 160, 161, and 167—are shown. All epitope-residue-based decomposition results appear in the Supporting Material
(Table S8). All units are in kcal/mol.
2708 Ieong et al.of the L1 and L3 loops did not affect the interface volumes
between Ig-2D1 and 09HA and 09HA_mut significantly:
5155.2 5 12.7 A˚ and 5382.0 5 15.7 A˚, respectively. This
result suggests that key structural changes occurred on the
antibody Ig-2D1 L1 and L3 loops.
Destabilization of the K158 salt bridge in 09HA
The 09HA retained the K167-D93 salt bridge but lost the
K158-D54 salt bridge found between 18HA and Ig-2D1.
The DG contribution of K158 was estimated to be
4.4 5 0.2 kcal/mol in the 18HA (Table 3). The K158
salt bridge was unstable in the 09HA system and did not
meet the 75% occupancy threshold. Of the epitope residues,
only two mutations occurred between 18HA and 09HA:
S160N and V170I, respectively. As a result, the DG ofFIGURE 2 Loop motions near Glu 167 in 09HA_mut. (A) The position
of Glu (E) 167 relative to the CDR L3 loop (yellow), at the beginning of
the simulation. (B) After the end of the simulation, the loops moved
away from the HA and the CDR L3 (orange) was further away from the
Glu167. (C) The number of Ig-2D1 atoms (y axis) within 4.6 A˚ of K167
(09HA, red) and E167 (09HA_mut, black) over time (x axis). To see this
figure in color, go online.
Biophysical Journal 108(11) 2704–271209HA and Ig-2D1 interaction increased by þ6.4 5
1.6 kcal/mol. The biggest free-energy contribution differ-
ence between 18HA and 09HA occurred at K158 and
N160, with no significant differences observed from residue
161 onward (Fig. 3), including residues K167 and the V170I
mutation. Thus, the difference observed at S160N may be
the major mutation that affects the stability of the K158-
D54 salt bridge.
S160 contributed 4.95 0.2 kcal/mol to 18HA interac-
tion with Ig-2D1, whereas N160 contributed little to the
09HA interaction with the latter (Table 3). Throughout the
simulation, S160 (18HA) formed two H-bonds and two
dipole-dipole interactions with Ig-2D1 (Table S2), whereas
no equivalent interactions were found for N160 (09HA)
(Table S3). Here we note that only one dipole-dipole inter-
action for S160 (18HA) is identified through crystal struc-
ture examination only, whereas all the interactions at
K167 (18HA) are observed in the simulation and the crystal
structure (Table S2).
We examined the volume between S160 (18HA) and
N160 (09HA) and adjacent Ig-2D1 residues (Table 4). There
was close to a 50% increase in the solvent-accessible vol-
ume from 18HA to 09HA. The extra volume allowed
more water molecules to enter the protein interface
(Fig. 4). Thus, it is likely that the S160N mutation led to
increased solvent accessibility and formation of a water cav-
ity, with a destabilizing effect on the K158-D54 salt bridge
(Table S3).
Of the 20 epitope residues, the other mutation between 18
HA and 09HA is V170I. We did not find any significant in-
teractions between HA and Ig-2D1 at position 170 during
our simulations (Tables S2 and S3). Overall, the S160N
could be a major contributing factor to the lower binding af-
finity of 09HA by Ig-2D1, in conjunction with the loss of the
K158-D54 salt bridge.
Compared with 18HA, 06HA also lost the K158-D54 salt
bridge with Ig-2D1. The K158 (06HA) contributed similarly
to the K158 (09HA) but only half as much as the K158
(18HA) to theDGof Ig-2D1 binding. However, 10 additional
mutations in the epitopes of 06HA resulted in a similarDG as
09HA overall (Tables 3 and S8). Of these, L161 (06HA) low-
eredDG from the VDWinteractionwith R97 (IgH) (Fig. S1).
It contributed 4.0 kcal/mol5 0.1kca/mol compared with
FIGURE 3 The free energy differences squared
are shown for all epitope residues between 18HA
and 09HA. Y axis is the energy difference squared,
DDG2¼(DG18HADG09HA)2, and x axis are the
residue name and residue ID from 18HA. The
two mutations are S160N and V170I from 18HA
to 09HA. Detailed data may be found in Tables 3
and S8.
Immune Recognition and Escape for H1N1 27091.8kcal 5 0.1kcal/mol from S161 (18HA) (Table 3). This
decrease of 2.2 kcal/mol 5 0.1kcal/mol in DG suggests
that the S161L mutation from a polar amino acid to a hydro-
phobic residue is favorable within the context of all the other
compensatory mutations in 06HA.DISCUSSION
Role of salt bridges on the stability of the
antigen-antibody complex
In an earlier study, Krause et al. reported that Ig-2D1 against
18HA may cross-react with 09HA and identified the K167E
mutation from experimental screening for escape mutants to
Ig-2D1. These escape mutants are no longer neutralized by
the Ig-2D1 antibody. We obtained results consistent with
these experimental observations through MD simulation.
The 09HA_mut had the lowest binding affinity to Ig-2D1
(Table 2). In addition, residue-based, free-energy decompo-
sition also confirmed that K167 is a key residue in the bind-
ing of Ig-2D1.
Others have similarly predicted the importance of this
residue using hot-spot analysis (21). Xu et al. determined
from crystal structural and experimental mutation studies
that the K167 plays a key role in forming a salt bridge be-
tween Ig-2D1 and 18HA (12,14). When K167 was mutated
to E, Q, or P, the dissociation constant Kd drastically
increased. As these studies are based on crystal structures
alone or single-residue mutagenesis, they offer limitedTABLE 4 POVME volumes of 18HA and 09HA surrounding
S/N160
18HA 09HA
Volume (A˚3) 1317.2 1922.9
SE (A˚3) 13.6 17.7mechanistic insights on how K167 affects antigen-antibody
interactions.
K167 (09HA) is a positively charged amino acid residue
that forms a salt bridge with negatively charged D93 (IgL).
When it is mutated to E167 (09HA_mut), the two negative
amino acid residues, E167 and D93, were thermodynami-
cally unstable close together. In our MM-PB/GBSA results,
the 09HA_mut bound only half as strongly as 18HA to Ig-
2D1 with a DG of 37.95 1.6 kcal/mol. Since 09HA_mut
is not expected to bind, or binds poorly, to Ig-2D1, the nega-
tive DG could be because of the experimental setup of the
simulation. The 09HA_mut system bound to Ig-2D1 was
constructed artificially by superimposing the 09HA_mut
and 18HA/Ig-2D1 co-crystal structures (12). Consequently,
09HA_mut was placed in close proximity to Ig-2D1, a state
that may not occur in nature because of entropic barriers.
Over the length of the simulation, Ig-2D1 remained
bound to 09HA_mut, with a number of favorable antigen/
antibody interactions that the mutant model inherited from
its 18HA/Ig-2D1 crystallographic template. However, the
electrostatic repulsion between E167 and D93 eventually
led to the loss of other favorable interactions between the
antigen and the antibody (Table 1). In particular, two
H-bond interactions were lost and not replaced between
the 09HA and 09HA_mut systems.Relative binding affinities of Ig-2D1 to HAs
Krause et al. reported that the Ig-2D1 concentration taken to
neutralize 09HA is 0.04 mg/ml compared with 0.025 mg/ml
required for 18HA, suggesting that the binding affinity of
Ig-2D1 to 09HA is lower (14). In contrast, Liu et al. (21)
predicted, using a single-frame reconstructed antigen-anti-
body system, that six mutations on the 09HA could help
the antigen to bind more strongly to Ig-2D1. OurBiophysical Journal 108(11) 2704–2712
FIGURE 4 The S160N mutation and water pocket formation. The num-
ber of water molecules within 5 A˚ of 18HA S160 (black) and 09HA N160
(red) as a function of simulation time. To see this figure in color, go online.
2710 Ieong et al.simulations determined that the 09HA had weaker binding
affinity with Ig-2D1, compared with 18HA, in agreement
with the results of Krause et al.
Liu et al. (21) did not identify a role for N160 in the inter-
action between 09HA and Ig-2D1. Our free-energy decom-
position analysis revealed that S160 in 18HA contributed
more to binding than N160 in 09HA. Relatively speaking,
the S160N mutation weakened the interaction between
Ig-2D1 and HA.
The S160N mutation could destabilize the K158-D54
(IgH) salt bridge in the simulations by increasing solvent
accessibility and formation of water pockets. This may be
because of the loss of hydrogen bonds established by
S160 from 18HA in 09HA. Even though S and N are polar
amino acid residues, we did not observe any persistent H
bonds or other interactions with N160 in 09HA (Table
S5). The increased water present in the antibody-antigen
interface could further weaken the electrostatic interactions
from the salt bridges formed. Thus, the S160N mutation is
likely to have a destabilizing effect on the K158-D54 salt
bridge important in the antigen-antibody complex forma-
tion. This result also suggests that the antibody may be
recognizing a spatial conformation presented by S160, but
not N160.
In summary, Ig-2D1 has a higher DG toward 09HA
compared with its native 18HA antigen primarily because
of a S160N mutation and its secondary effects. This conclu-
sion demonstrates the advantages of MD simulation, which
allows the antigen to change, based on antibody dynamics,
and represents a more realistic physiological setting.
The 09HA had only two mutations compared with the
18HA in the epitopes, of which S160N allowed partial
escape from the cross-reactive 18HA antibody Ig-2D1.
The 06HA, with 10 mutations in the epitope residues, was
still recognized by Ig-2D1 at a similar affinity as theBiophysical Journal 108(11) 2704–271209HA in silico. Next we discuss how the 06HA might be
able to escape from Ig-2D1 immune recognition in vivo.Effect of glycosylation on 06HA recognition
The DGs of the 06HA and 09HA systems were 67.6 5
1.6 kcal/mol and 68.05 1.2 kcal/mol, respectively. How-
ever, 06HA is not neutralized by Ig-2D1 experimentally.
Our sequence analysis revealed that this is likely because
of mutations in 06HA that introduce glycosylation in vivo,
which provides the necessary immune escape (Fig. 1 B).
K164 from the 18HA is mutated to N164 in the 06HA.
This K164N mutation introduced a glycosylation site on
the Sa epitope. Another E131T mutation added a glycosyl-
ation site at position 129.
Glycosylation has been suggested as a defense mecha-
nism against antibody neutralization (5,19,39). The carbo-
hydrates attached on epitopes cause steric crash with
antibodies. In our simulation, the 06HA system was ungly-
cosylated. During system setup, all carbohydrates were
removed. Thus, the Sa epitope was exposed to Ig-2D1
without any steric hindrance. The DG free-energy calcula-
tion results suggest Ig-2D1 could neutralize the unglycosy-
lated 06HA.
Thus, the in-silico experimental construct allowed Ig-2D1
to bind/neutralize the 06HA even though it may not be
feasible under physiological conditions where glycosylation
is present. We cannot exclude other mechanisms in play
here, because there are more mutations of 06HA among
the epitope residues. For example, in this case, spatial con-
formations may be more important in epitope recognition by
Ig2-2D1. Nonetheless, our observations suggest a mecha-
nism for immune augmentation through which glycosyla-
tion inhibitors may enhance protection from preexisting
antibodies or immune memory.MM-PB/GBSA analysis for relative binding-energy
determination
The PB model for implicit solvent was considered more ac-
curate than the GBmethod for free-energy calculations (40).
However, recent research has shown that the GB implicit-
solvent model may be better at predicting relative binding
energy than the PB model (41). In the current work, both
the GB and PB models performed similarly, as judged by
the relative DG rankings of the four HA/Ig-2D1 systems
studied (Table 2). MM-PBSA is relatively fast and could
predict relative binding energy very well (42), and our
results provided further support for the validity of MM-
PBSA in the antibody-antigen systems studied. Other meth-
odologies have been reported in the literature to calculate
the free energy of binding, including free-energy perturba-
tion (FEP) and thermodynamic integration (TI) (43,44).
Even though both of these methods can produce DG values
Immune Recognition and Escape for H1N1 2711that closely match experiment values, they are computation-
ally more expensive.
Xia et al. used FEP to determine the DDGs between
different HAs and monoclonal antibodies. Their results
showed that a single escape mutation would increase the
DDG by 7.28–15.47 kcal/mol (43). Interestingly, our
decomposition energy also showed that the K167E mutation
contributed 9.2 5 0.3 kcal/mol to the total DG of the
09HA_mut system. Since DG calculation with MM-PB/
GBSA for a salt bridge is often overestimated if the salt
bridge is buried between two protein interfaces (45),
the þ9.2 5 0.3 kcal/mol difference in energy could be
the upper-bound limit. Other residues that Xia et al. sug-
gested would change binding affinity without being detri-
mental to antibody-antigen interactions had reported DDG
values <4.24 kcal/mol. Our results also predicted that, for
mutations that do not reverse binding, theirDDGs in decom-
position energies were also <2.2 kcal/mol.Entropy consideration in relative binding-energy
determination
Conformational entropy has been implicated in the antibody
maturation process whenmutations in the Fab and Fc regions
modulate the binding of antibodies to antigens (46). In our
simulation, we did not consider entropic contributions in
our specific systems for several reasons. First, the systems
are similar in their binding states, as shown through RMSD
analyses. HA receptor-binding domains are very rigid: only
side-chain movements were observed. Second, no major
conformational changes were observed in the antibody or an-
tigen. This observation is in contrast to that of our previous
study in which glycan receptors adopted significant changes
upon HA binding, and entropy consideration was necessary
to obtain results consistent with experimental studies (46).
Third, because we are considering the relative free energy
of binding of complexes between highly conserved HAs and
the same antibody, it is likely that the entropic differences
would cancel out. Hou et al. discussed in detail that the in-
clusion of entropy consideration is not predictive of accu-
racy in all systems when relative DG (DDG) is calculated.
In fact, many previous studies have ranked relative affinities
of ligands successfully without entropy consideration (41).
However, this does not mean entropy considerations may
be ignored for relative binding affinities, as shown in (46).
It is especially crucial when absolute binding energy is
considered (41).
Fourth, entropy consideration is computationally costly
using nmode, and the margin of error may fluctuate widely
depending on the choice of frames used in the calculations.
Convergence is often an issue when using quasiharmonic
analysis (48), especially given the sizes of our systems
(data not shown). Therefore, the inclusion of entropic consid-
eration may improve the correlation with experimental data,
but it is beyond the scope of our current hypotheses.CONCLUSIONS
Our computational results from MM-GB/PBSA are consis-
tent with experimental observations reported in the litera-
ture. The formation of two salt bridges plays a key role in
the immune recognition of Ig-2D1 of the 18HA and cross-
reactivity with the 09HA. The stability of the K158-D54
(IgH) salt bridges is dramatically weakened by the S160N
mutation in the 09HA and is accompanied by hydrogen
bond loss and water pocket formation at the antibody-anti-
gen interface. The immune escape of the 09HA may be
accomplished through a K167E mutation, which completely
disrupts both salt bridges between 09HA and Ig-2D1. On the
other hand, the 06HA likely achieves immune escape
through mutations that introduce glycosylation sites and
mask epitope residues. These results provide mechanistic
insights into the immune recognition and escape of the
H1N1 virus. In addition, they could inform the design of
better antibodies against this pandemic strain and protection
from future threats.SUPPORTING MATERIAL
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